文献速递糖尿病

2型糖尿病模型的患者健康效用方程

Patient Health Utility Equations for a Type 2 Diabetes Model.
PubMed 文献 · Diabetes Care · 2020-12-04

该研究基于ACCORD与Look AHEAD试验及其随访数据,纳入15252名2型糖尿病患者、平均随访8.2年、共128873人次观察,采用固定效应回归估计糖尿病相关并发症对健康效用的影响。卒中、截肢、充血性心力衰竭、透析、eGFR<30、心绞痛和心肌梗死等并发症与显著健康效用下降相关,估计值可用于改善成本效果模型与糖尿病政策制定。

要点

  • 卒中事件与病史的健康效用减量分别为-0.109与-0.051。
  • 截肢事件与病史的效用减量分别为-0.092与-0.150。
  • 透析病史、心绞痛事件、心梗病史等减量不显著(P≥0.05)。

核心结论

  • 基于大样本纵向设计估计的健康效用分值预期基本无偏,可用于描述并发症的健康效用影响并改进成本效果模型。

研究设计与样本

  • 合并ACCORD与Look AHEAD试验及其随访的2型糖尿病患者健康效用指数Mark 3数据,采用固定效应回归模型估计并发症相关效用减量。
  • 样本包括15252人,平均随访8.2年,共128873人次观察。

主要发现

  • 卒中事件效用减量-0.109,卒中病史-0.051,均P<0.05。
  • 截肢事件效用减量-0.092,截肢病史-0.150,均P<0.05。
  • 充血性心力衰竭事件-0.051、病史-0.041,透析事件-0.039,eGFR<30事件-0.043、病史-0.025,心绞痛病史-0.028,心肌梗死事件-0.028,均P<0.05。
  • 激光光凝和eGFR<60 mL/min/1.73 m2的效应较小。
  • 透析病史、心绞痛事件、心肌梗死病史、血运重建事件与病史、激光光凝事件及低血糖的效用减量不显著(P≥0.05)。

关键数值与推荐

  • 卒中事件效用减量-0.109,卒中病史-0.051(P<0.05)。
  • 截肢事件效用减量-0.092,截肢病史-0.150(P<0.05)。
  • 充血性心力衰竭事件-0.051、病史-0.041(P<0.05)。
  • 透析事件-0.039,eGFR<30事件-0.043、病史-0.025(P<0.05)。
  • 心绞痛病史-0.028,心肌梗死事件-0.028(P<0.05)。

临床怎么用

  • 可将上述效用减量用于2型糖尿病成本效果模型,量化并发症对健康效用的影响。
  • 可为糖尿病相关政策制定提供基于大样本纵向数据的效用参数参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To estimate the health utility impact of diabetes-related complications in a large, longitudinal U.S. sample of people with type 2 diabetes. RESEARCH DESIGN AND METHODS: We combined Health Utilities Index Mark 3 data on patients with type 2 diabetes from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) and Look AHEAD (Action for Health in Diabetes) trials and their follow-on studies. Complications were classified as events if they occurred in the year preceding the utility measurement; otherwise, they were classified as a history of the complication. We estimated utility decrements associated with complications using a fixed-effects regression model. RESULTS: Our sample included 15,252 persons with an average follow-up of 8.2 years and a total of 128,873 person-visit observations. The largest, statistically significant (P < 0.05) health utility decrements were for stroke (event, -0.109; history, -0.051), amputation (event, -0.092; history, -0.150), congestive heart failure (event, -0.051; history, -0.041), dialysis (event, -0.039), estimated glomerular filtration rate (eGFR) <30 mL/min/1.73 m2 (event, -0.043; history, -0.025), angina (history, -0.028), and myocardial infarction (MI) (event, -0.028). There were smaller effects for laser photocoagulation and eGFR <60 mL/min/1.73 m2. Decrements for dialysis history, angina event, MI history, revascularization event, revascularization history, laser photocoagulation event, and hypoglycemia were not significant (P ≥ 0.05). CONCLUSIONS: With use of a large study sample and a longitudinal design, our estimated health utility scores are expected to be largely unbiased. Estimates can be used to describe the health utility impact of diabetes complications, improve cost-effectiveness models, and inform diabetes policies.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Neuwahl SJ, Zhang P, Chen H, et al. Patient Health Utility Equations for a Type 2 Diabetes Model. Diabetes Care. 2020. PMID: 33277301. doi:10.2337/dc20-1207

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。